EA200301323A1 - Однократная вакцинация mycoplasma hyopneumoniae - Google Patents

Однократная вакцинация mycoplasma hyopneumoniae

Info

Publication number
EA200301323A1
EA200301323A1 EA200301323A EA200301323A EA200301323A1 EA 200301323 A1 EA200301323 A1 EA 200301323A1 EA 200301323 A EA200301323 A EA 200301323A EA 200301323 A EA200301323 A EA 200301323A EA 200301323 A1 EA200301323 A1 EA 200301323A1
Authority
EA
Eurasian Patent Office
Prior art keywords
vaccine
hyo
mycoplasma hyopneumoniae
administered
present
Prior art date
Application number
EA200301323A
Other languages
English (en)
Other versions
EA009901B1 (ru
Inventor
Робин Ли Кич
Лайза Грейс Саббадини
Original Assignee
Пфайзер Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23168589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200301323(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк.
Publication of EA200301323A1 publication Critical patent/EA200301323A1/ru
Publication of EA009901B1 publication Critical patent/EA009901B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к способам лечения или предупреждения заболевания или нарушения у животного, вызванного Mycoplasma hyopneumoniae (M. hyo), при котором этому животному в возрасте приблизительно от трех (3) до десяти (10) суток вводят однократную дозу эффективного количества M. hyo вакцины. M. hyo вакцина может представлять собой инактивированный или модифицированный живой препарат на основе целых клеток или их частей, субъединичную вакцину или вакцину на основе нуклеиновых кислот или ДНК. M. hyo вакцина, вводимая в соответствии с настоящим изобретением, может быть синтезирована или получена рекомбинантным путем.Отчет о международном поиске был опубликован 2004.07.29.
EA200301323A 2001-07-02 2002-06-07 Способ лечения или предупреждения заболевания или нарушения у животного, вызванного mycoplasma hyopneumoniae EA009901B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30263601P 2001-07-02 2001-07-02
PCT/IB2002/002121 WO2003003941A2 (en) 2001-07-02 2002-06-07 One dose vaccination with mycoplasma hyopneumoniae

Publications (2)

Publication Number Publication Date
EA200301323A1 true EA200301323A1 (ru) 2005-06-30
EA009901B1 EA009901B1 (ru) 2008-04-28

Family

ID=23168589

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200301323A EA009901B1 (ru) 2001-07-02 2002-06-07 Способ лечения или предупреждения заболевания или нарушения у животного, вызванного mycoplasma hyopneumoniae

Country Status (42)

Country Link
US (3) US6846477B2 (ru)
EP (3) EP2842569B1 (ru)
JP (1) JP2005515162A (ru)
KR (1) KR20040030785A (ru)
CN (3) CN102872456B (ru)
AP (1) AP2003002937A0 (ru)
AR (1) AR034678A1 (ru)
AT (1) ATE412426T2 (ru)
AU (1) AU2002309109B2 (ru)
BG (1) BG66481B1 (ru)
BR (1) BR0210804A (ru)
CA (1) CA2451626C (ru)
CY (1) CY1108749T1 (ru)
CZ (1) CZ305781B6 (ru)
DE (1) DE60229666D1 (ru)
DK (3) DK2842569T3 (ru)
DO (1) DOP2002000431A (ru)
EA (1) EA009901B1 (ru)
ES (3) ES2550458T3 (ru)
GT (1) GT200200138A (ru)
HK (4) HK1068250A1 (ru)
HR (1) HRP20031079A2 (ru)
HU (1) HU230246B1 (ru)
IL (1) IL159349A0 (ru)
IS (1) IS7076A (ru)
MA (1) MA27047A1 (ru)
MX (1) MXPA03011599A (ru)
NO (1) NO342654B1 (ru)
NZ (1) NZ530106A (ru)
OA (1) OA12638A (ru)
PA (1) PA8549701A1 (ru)
PE (1) PE20030285A1 (ru)
PL (1) PL209773B1 (ru)
PT (3) PT1474067E (ru)
SK (1) SK288010B6 (ru)
TN (1) TNSN03155A1 (ru)
TW (1) TWI329514B (ru)
UA (1) UA78707C2 (ru)
UY (1) UY27366A1 (ru)
WO (1) WO2003003941A2 (ru)
YU (1) YU102203A (ru)
ZA (1) ZA200309698B (ru)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
WO2006056841A1 (en) * 2004-11-24 2006-06-01 Pharmacia & Upjohn Company Llc Multiple-strain mycoplasma hyopneumoniae vaccines
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
BR122015028489B1 (pt) 2005-12-29 2021-10-13 Boehringer Ingelheim Animal Health Usa Inc Vacina de combinação multivalente contra pcv2, bem como uso de uma proteína orf2 na preparação da mesma
EP2371385B1 (en) 2005-12-29 2015-08-19 Boehringer Ingelheim Vetmedica, Inc. Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
MX2008011247A (es) * 2006-03-03 2008-09-11 Merial Ltd Vacuna de micoplasma hyopneumoniae.
EP2099927A4 (en) * 2006-11-22 2010-05-05 Boehringer Ingelheim Vetmed METHODS FOR REDUCING FLAMBEES OF DISEASES ASSOCIATED WITH PORCINIC CIRCOVIRUS
EP2859900A1 (en) 2006-12-11 2015-04-15 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
CA2670836C (en) 2006-12-15 2018-09-04 Boehringer Ingelheim Vetmedica, Inc. Treatment of pigs with pcv2 antigen
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
AU2008324780A1 (en) 2007-11-06 2009-05-14 Pah W Llc Mycoplasma hyopneumoniae avirulent -adjuvanted live vaccine
BRPI0821456A2 (pt) * 2007-12-31 2015-06-16 Boehring Ingelheim Vetmedica Inc Partícula similar à pcv2 orf2 com inserção de aminoácido estranho
CN101236206B (zh) * 2008-01-17 2014-10-15 中国兽医药品监察所 一种猪肺炎支原体重组抗原elisa检测试剂盒
MX2010007815A (es) * 2008-01-23 2010-08-10 Boehringer Ingelheim Vetmed Composiciones inmunogenicas de mycoplasma hyopneumoniae contra pcv2 y metodos para producir composiciones de este tipo.
US8444989B1 (en) * 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
ES2728949T3 (es) * 2008-06-27 2019-10-29 Zoetis Services Llc Composiciones adyuvantes novedosas
CA2764424C (en) 2009-06-04 2019-12-31 National Institute Of Advanced Industrial Science And Technology Vaccine for mycoplasma infection
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
PL2569007T3 (pl) 2010-05-11 2016-04-29 Intervet Int Bv Szczepionka przeciwko Mycoplasma Hyopneumoniae, odpowiednia do podawania w obecności przeciwciał pochodzących od matki
KR102157718B1 (ko) * 2010-07-26 2020-09-18 큐 바이올로직스 인코포레이티드 면역원성 소염 조성물
US8546149B2 (en) 2010-08-27 2013-10-01 Intervet Inc. Potency test for vaccine formulations
HUE028877T2 (en) * 2010-08-27 2017-01-30 Intervet Int Bv Test of biological activity of vaccine formulation
LT2691530T (lt) 2011-06-10 2018-08-10 Oregon Health & Science University Cmv glikoproteinai ir rekombinantiniai vektoriai
MX362166B (es) * 2012-03-07 2018-12-14 Ceva Sante Animale Nueva vacuna veterinaria.
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
SG10201708028VA (en) 2012-12-28 2017-10-30 Boehringer Ingelheim Vetmedica Gmbh Method of making a mycoplasma vaccine
CN104981252B (zh) 2012-12-28 2019-06-18 勃林格殷格翰动物保健有限公司 包含支原体抗原的免疫原性组合物
KR101773486B1 (ko) * 2013-02-05 2017-08-31 애그리컬쳐럴 테크놀로지 리서치 인스티튜트 항-마이코플라즈마 에스피피. 아단위 백신
CN104338125A (zh) * 2013-07-29 2015-02-11 普莱柯生物工程股份有限公司 一种猪肺炎支原体抗原在预防和治疗猪呼吸道疾病综合征方面的应用
WO2015042369A2 (en) 2013-09-19 2015-03-26 Zoetis Llc Oil-based adjuvants
EA035265B1 (ru) 2013-10-02 2020-05-21 Бёрингер Ингельхайм Энимал Хелс Ю-Эс-Эй Инк. Вариант белка opc2 pcv2 и содержащие его вирусоподобные частицы
RU2646137C2 (ru) * 2013-11-21 2018-03-01 Эгрикалчурал Текнолоджи Рисерч Инститьют КОМПОЗИЦИЯ ПО ПРЕДУПРЕЖДЕНИЮ ИНФЕКЦИИ Mycoplasma spp.
CN105012948B (zh) * 2014-04-18 2019-07-30 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
CN104248753B (zh) * 2014-05-15 2017-07-28 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
BR102014014727B1 (pt) * 2014-06-16 2018-04-03 Ouro Fino Saúde Animal Ltda COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, GENE SINTÉTICO CODIFICANTE DO COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, COMPOSIÇÃO ANTIGÊNICA, PROCESSO DE OBTENÇÃO DE UM COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae
US9814769B2 (en) 2014-09-30 2017-11-14 Qatar University Vaccines against pathogenic Escherichia coli and methods of using the same
PL3244920T3 (pl) 2015-01-16 2023-09-25 Zoetis Services Llc Szczepionka przeciw pryszczycy
KR20160099223A (ko) * 2015-02-12 2016-08-22 강원대학교산학협력단 마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법
EP3498847A4 (en) * 2016-08-12 2020-03-04 Innovac VACCINE COMPOSITION FOR PREVENTING SWINE MYCOPLASM INFECTION COMPRISING A RECOMBINANT PROTEIN
RU2668799C1 (ru) * 2017-09-08 2018-10-02 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp.
CN108101969A (zh) * 2017-11-13 2018-06-01 南京大爻网络科技有限公司 一种与猪支原体肺炎相关的抗原及其应用
RU2695679C1 (ru) * 2018-09-11 2019-07-25 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp.
RU2759427C2 (ru) * 2019-07-08 2021-11-12 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp
CN117305192A (zh) * 2023-12-01 2023-12-29 北京瑞阳瑞泰生物科技有限公司 一种猪肺炎支原体rt02株、疫苗组合物及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252328A (en) 1987-03-26 1993-10-12 Martin Marietta Energy Systems, Inc. Mycoplasma hyopneumoniae antigen and uses therefor
EP0283840A3 (en) * 1987-03-26 1989-08-09 Ml Technology Ventures, L.P. Mycoplasma hyopneumoniae antigen and uses therefor
EP0307976B1 (en) 1987-09-18 1993-06-23 Akzo Nobel N.V. Mycoplasma vaccine
HUT65827A (en) 1990-04-02 1994-07-28 Synergen Inc Polypeptides useful in animal treatment against mycoplasma infections
DE69128361T3 (de) * 1990-05-29 2006-04-13 Wyeth Holdings Corp. Impfstoff gegen die pneumonie bei schweinen und verfahren zu seiner herstellung
US6113916A (en) * 1990-05-29 2000-09-05 American Cyanamid Company Method of enhancing cell mediated immune responses
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
EP0475185A1 (en) 1990-08-27 1992-03-18 Nippon Flour Mills Co., Ltd. DNA's encoding surface antigen of mycoplasma hyopneumoniae, DNA fragments for primer, recombinant antigenic peptides and diagnostic method of mycoplasmal pneumoniae of swine using same
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
ATE273022T1 (de) * 1992-09-28 2004-08-15 Wyeth Corp Verfahren zur verstärkung zellularer immunantworten
US5530874A (en) 1993-02-02 1996-06-25 3Com Corporation Network adapter with an indication signal mask and an interrupt signal mask
WO1995009870A1 (en) 1993-10-07 1995-04-13 Iowa State University Research Foundation, Inc. Characterization of mycoplasma hyopneumoniae adhesins
SI0759780T1 (en) 1994-05-10 2000-12-31 American Home Products Corporation Improved modified live brsv vaccine
US5788962A (en) 1995-01-17 1998-08-04 The Curators Of The University Of Missouri DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures
AUPN178995A0 (en) * 1995-03-16 1995-04-13 University Of Melbourne, The Antigen composition
US6440408B2 (en) 1996-09-30 2002-08-27 University Of Arkansas Method of treatment
EP0846468B1 (en) 1996-12-05 2004-06-09 Akzo Nobel N.V. Non-virulent mycoplasma synoviae and vaccine thereof
HUP0100130A2 (hu) 1997-11-26 2001-05-28 Iowa State University Research Foundation, Inc. Rekombináns Mycoplasma hyopneumoniae vakcina
AU6128900A (en) * 1999-09-29 2001-04-05 Pfizer Products Inc. Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof
US6585981B1 (en) * 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs

Also Published As

Publication number Publication date
BG66481B1 (bg) 2015-02-27
BG108546A (bg) 2005-02-28
ZA200309698B (en) 2014-04-30
UY27366A1 (es) 2003-04-30
EP2027873B8 (en) 2015-11-11
US20030109473A1 (en) 2003-06-12
EP1474067A4 (en) 2005-08-10
TNSN03155A1 (fr) 2005-12-23
CA2451626A1 (en) 2003-01-16
DK1474067T4 (en) 2017-10-16
PT1474067E (pt) 2008-11-14
CZ20033466A3 (cs) 2005-06-15
HRP20031079A2 (en) 2005-10-31
DK2842569T3 (da) 2019-05-20
US6846477B2 (en) 2005-01-25
DK2027873T3 (en) 2015-11-09
EP1474067B1 (en) 2008-10-29
ATE412426T2 (de) 2008-11-15
YU102203A (sh) 2006-05-25
AU2002309109B2 (en) 2007-12-13
PT2842569T (pt) 2019-06-17
EP2027873B1 (en) 2015-09-09
ES2312580T3 (es) 2009-03-01
CA2451626C (en) 2011-05-31
IS7076A (is) 2003-12-15
KR20040030785A (ko) 2004-04-09
EP2027873A1 (en) 2009-02-25
EP1474067A2 (en) 2004-11-10
DE60229666D1 (de) 2008-12-11
BR0210804A (pt) 2005-05-03
CY1108749T1 (el) 2014-04-09
HK1134900A1 (en) 2010-05-20
CN1551781B (zh) 2013-01-02
OA12638A (en) 2006-06-15
MXPA03011599A (es) 2005-03-07
WO2003003941A2 (en) 2003-01-16
GT200200138A (es) 2003-05-15
SK288010B6 (sk) 2012-10-02
NO20035762L (no) 2004-02-02
HK1068250A1 (en) 2005-04-29
HUP0400434A2 (en) 2007-08-28
HK1180224A1 (zh) 2013-10-18
ES2312580T5 (es) 2017-12-11
PA8549701A1 (es) 2003-01-24
MA27047A1 (fr) 2004-12-20
TWI329514B (en) 2010-09-01
UA78707C2 (en) 2007-04-25
CN1551781A (zh) 2004-12-01
DOP2002000431A (es) 2003-01-15
PT2027873E (pt) 2015-11-03
PE20030285A1 (es) 2003-03-27
EA009901B1 (ru) 2008-04-28
JP2005515162A (ja) 2005-05-26
EP2842569A1 (en) 2015-03-04
CN101524532A (zh) 2009-09-09
AR034678A1 (es) 2004-03-03
IL159349A0 (en) 2004-06-01
PL209773B1 (pl) 2011-10-31
CN101524532B (zh) 2014-03-19
US20050013823A1 (en) 2005-01-20
ES2729579T3 (es) 2019-11-04
EP2842569B1 (en) 2019-04-10
NZ530106A (en) 2007-06-29
CN102872456B (zh) 2016-01-20
HU230246B1 (hu) 2015-11-30
PL373367A1 (en) 2005-08-22
CN102872456A (zh) 2013-01-16
WO2003003941A3 (en) 2004-07-29
ES2550458T3 (es) 2015-11-10
DK1474067T3 (da) 2008-12-08
SK15792003A3 (sk) 2005-09-08
EP1474067B2 (en) 2017-08-16
CZ305781B6 (cs) 2016-03-16
AP2003002937A0 (en) 2003-12-31
HK1207584A1 (en) 2016-02-05
USRE44399E1 (en) 2013-07-30
NO342654B1 (no) 2018-06-25

Similar Documents

Publication Publication Date Title
EA200301323A1 (ru) Однократная вакцинация mycoplasma hyopneumoniae
EA200301324A1 (ru) Вакцина mycoplasma bovis и способы сокращения пневмонии у животных
MXPA03011924A (es) Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado.
BRPI0614119B8 (pt) vacina para imunizar gatos contra calicivírus de felino
RU2010149495A (ru) Новые адъювантные композиции
ATE476510T1 (de) Schweine-circovirus-impfstoff in rekombinantem pockenvirus
CO5611162A2 (es) Metodos para prevenir enfermedades reproductivas en el ganado vacuno
NO20011586D0 (no) Nye metoder for terapeutisk vaksinasjon
HU206989B (en) Process for producing vaccines comprising tocols as adjuvant
BR0113109A (pt) Anticorpos antil-il-12, composições, métodos e usos
BR0111366A (pt) Vacina de poxvìrus recombinante do vìrus da sìndrome respiratória e reprodutiva de porcino (prrsv)
RU2010120324A (ru) Вакцина против вируса синего языка и иммуногенные композиции, способы их применения и способы их получения
Ataei et al. Identification of immunogenic proteins associated with protection against haemorrhagic septicaemia after vaccination of calves with a live-attenuated aroA derivative of Pasteurella multocida B: 2
DE69635472D1 (de) Impfstoff gegen Geflügelkokzidose
CY1116862T1 (el) Εμβολιασμος μιας δοσης me mycoplasma hyopneumoniae
BR0112486A (pt) Poliproteìna, molécula de ácido nucleico, plasmìdeo, vacina recombinante ou vacina atenuada, composição farmacêutica, e, método para imunizar um indivìduo contra hiv
DE60035485D1 (de) IDENTIFIZIERUNG VON SPEZIFISCHEN DIFFERENZIELL EXPRIMIERTEN ANTIGENEN AUS MYCOBACTERIUM UND MEDIZINISCHE VERWENDUNG DER MYCOBAKTERIUMPROTEINE Rv0068 UND Rv3407
BR0110791A (pt) Composição, métodos para induzir uma resposta imune em um indivìduo contra um imunogene, para modular o sistema imune de um indivìduo e para imunizar um indivìduo contra um patógeno, vacina recombinante, e patógeno atenuado vivo
BRPI0413290A (pt) composto para a vacinação de um animal, molécula de ácido nucleico, vetor de expressão, célula hospedeira, vacina, composição farmacêutica, métodos para imunizar um animal contra uma doença, e para combater uma doença em um animal, doença em animal, uso de um composto e um ácido nucleico, e para determinar se a um animal foi administrado com um composto, kit de partes, e, método para vacinar um animal
Nieves et al. Subcutaneous rabies vaccination of pigtail macaques
PT1194450E (pt) Vacina inactivada contra a calicivirose felina
DE60027419D1 (de) Regulatorische Sequenzen des humanen MCP-1 Gens
El-Bagoury et al. Evaluation of inactivated Rift valley fever virus vaccine adjuvanted with montanide oil ISA 201 VG
ES2172482B1 (es) Adicion de la patente es200100402 "vacuna para la proteccion de perros frente a la leishmania".
Buonavoglia et al. Duration of Immunity in Swine Inoculated with a Monovalent Foot‐and‐Mouth Disease Oil Emulsion Vaccine

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

PC4A Registration of transfer of a eurasian patent by assignment
TC4A Change in name of a patent proprietor in a eurasian patent
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title